ΧΡΗΣΗ VEGF ΚΑΙ ΟΜΟΛΟΓΩΝ ΣΤΗ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΝΕΥΡΩΝΙΚΩΝ ΔΙΑΤΑΡΑΧΩΝ

• Main Authors: CARMELIET Peter, COLLEN Désiré, OOSTHUYSE Bert
• Format: Patent
• Language: Greek
• Published: 05.04.2017
• Subjects: AGRICULTURE; ANIMAL HUSBANDRY; BEER; BIOCHEMISTRY; CARE OF BIRDS, FISHES, INSECTS; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; COMPOSITIONS THEREOF; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; CULTURE MEDIA; ENZYMOLOGY; FISHING; FORESTRY; HUMAN NECESSITIES; HUNTING; HYGIENE; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; NEW BREEDS OF ANIMALS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; SPIRITS; TRAPPING; VINEGAR; WINE

Η παρούσα εφεύρεση αφορά τη χρήση VEGF-A για την κατασκευή ενός φαρμάκου για τη θεραπευτική αγωγή οποιουδήποτε από μετωποκροταφική άνοια λοβού, νόσο Alzheimer, νόσο Parkinson, νόσο Huntington, και διαταραχές κινητήριων νευρώνων. The present invention relates to a use of VEGF-A for the manufacture of a medicament to treat any of frontotemporal lobe dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, and motor neuron disorders.